🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms

Recruitingn/aAges 18 Years - 80 YearsAllNanjing First Hospital, Nanjing Medical University
NCT07764081 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aimed to characterize the progression and risk fators of coronary artery aneurysms, and copmpare the outcomes across different management strategies

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Angiographically confirmed coronary artery aneurysm, defined as coronary dilation ≥1.5 times the adjacent normal reference vessel diameter. 2. Age 18-80 years. Exclusion Criteria: 1. Suboptimal image quality 2. Incomplete clinical data, including medical history, laboratory parameters, or follow-up records.
💊

What it tests

  • Not listed
📍

Where

1 site
Nanjing First Hospital
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy